Suppr超能文献

广藿香醇与不同聚合物的固体分散体表征:对抑制再沉淀和提高溶解速率的影响。

Characterization of solid dispersions of Patchouli alcohol with different polymers: effects on the inhibition of reprecipitation and the improvement of dissolution rate.

作者信息

Chen Yun Long, Liao Jin Bin, Liang Yong Zhuo, Xie Jian Hui, Wu Qiong, Lai Xiao Ping, Chen Jian Nan, Su Zi Ren, Lin Zhi Xiu

机构信息

School of Chinese Materia Medica, Guangzhou University of Chinese Medicine , Guangzhou , China .

出版信息

Drug Dev Ind Pharm. 2015 Mar;41(3):436-44. doi: 10.3109/03639045.2013.877482. Epub 2014 Jan 13.

Abstract

Solid dispersion technique is known to be an effective approach for the polymer to keep drugs stable in the solid state, thereby improving the dissolution rate and oral bioavailability through inhibiting reprecipitation in supersaturated solution. In this study, to evaluate the inhibitory effect of polyethylene glycol-6000 (PEG), Polyvinylpyrrolidone K30 (PVP) and Aminoalkyl methacrylate copolymer (Eudragit), the reprecipitation profiles were observed from supersaturated solutions of Patchouli alcohol (PA) in the presence and absence of the polymers. Furthermore, the dissolution profiles of PA solid dispersions formulated with PEG, PVP or Eudragit were compared for investigating the effect on improving dissolution of each polymer. Solid dispersions formulated with Eudragit were found to result in solution with the highest extent of supersaturation. By contrast, PEG and PVP were less effective. At equivalent supersaturation, all three polymers are capable of mitigating reprecipitation relative to that of PA alone. In addition, in the PA solid dispersion with Eudragit (E-SD (1/3)), the highest concentration of supersaturation of PA was maintained for prolonged time. These results unambiguously indicate that it is imperative to select the appropriate polymer and drug/polymer ratio in addition to considering the stability of the supersaturated solution, which was generated following dissolution of amorphous solid dispersion.

摘要

众所周知,固体分散技术是使聚合物在固态下保持药物稳定的有效方法,从而通过抑制过饱和溶液中的再沉淀来提高溶解速率和口服生物利用度。在本研究中,为了评估聚乙二醇-6000(PEG)、聚乙烯吡咯烷酮K30(PVP)和甲基丙烯酸氨基烷基酯共聚物(尤特奇)的抑制作用,观察了在有和没有聚合物存在的情况下,广藿香醇(PA)过饱和溶液的再沉淀情况。此外,比较了用PEG、PVP或尤特奇制备的PA固体分散体的溶出情况,以研究每种聚合物对改善溶出的影响。发现用尤特奇制备的固体分散体产生的溶液过饱和度最高。相比之下,PEG和PVP的效果较差。在同等过饱和度下,相对于单独的PA,所有三种聚合物都能够减轻再沉淀。此外,在含有尤特奇的PA固体分散体(E-SD(1/3))中,PA的最高过饱和浓度能长时间维持。这些结果明确表明,除了考虑无定形固体分散体溶解后产生的过饱和溶液的稳定性外,选择合适的聚合物和药物/聚合物比例也至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验